Fierce Healthcare7h
Health tech Q3 earnings recap—Hims & Hers, Doximity, Waystar
The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...
AOL2d
What's Going On With Hims & Hers Health Stock On Wednesday?
Health and wellness platform Hims & Hers Health, Inc. (NYSE:HIMS), which has gained traction for its ...
Amazon launches fixed pricing for treatment of conditions such as hair loss. Hims & Hers stock drops 24%
Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile ...
Benzinga.com3d
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. And retail traders ...
Drug Store News2d
Hims & Hers Health plans to launch generic of Novo Nordisk's Victoza
Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...
Hims & Hers Health: Another Blowout Quarter Ignored
Hims & Hers Health exceeded revenue expectations, achieved substantial subscriber growth, and remains undervalued in the ...
These Stocks Moved the Most Today: Walt Disney, Super Micro, Cisco, ASML, JD.com, Tapestry, Intuitive Machines, Hims & Hers, and More
Walt Disney’s earnings beat Wall Street estimates, Super Micro Computer extends losses, and Cisco posts fiscal first-quarter ...
Hims & Hers falls -17.7%
Hims & Hers (HIMS) is down -17.7%, or -$4.88 to $22.72. Published first on TheFly – the ultimate source for real-time, ...